186 related articles for article (PubMed ID: 15041392)
1. Early steroid withdrawal protocol using basiliximab in kidney transplantation.
Teraoka S; Sato S; Kai K; Kawase T; Nakamura M; Tojinbara T; Nakajima I; Fuchinoue S
Transplant Proc; 2004 Mar; 36(2 Suppl):478S-482S. PubMed ID: 15041392
[No Abstract] [Full Text] [Related]
2. Comparative study of clinical outcome in kidney transplantation between early steroid withdrawal protocol using basiliximab, calcineurin inhibitor, and mycophenolate mofetil and triple regimen consisting of calcineurin inhibitor, mycophenolate mofetil, and steroid.
Teraoka S; Sato S; Sekijima M; Iwado K; Urashima Y; Kudo S; Kai K; Koyama I; Tojinbara T; Nakajima I; Fuchinoue S
Transplant Proc; 2005 Mar; 37(2):791-4. PubMed ID: 15848533
[TBL] [Abstract][Full Text] [Related]
3. Early steroid withdrawal protocol with basiliximab, cyclosporine and mycophenolate mofetil in renal-transplant recipients.
Kato Y; Tojimbara T; Iwadoh K; Koyama I; Nanmoku K; Kai K; Sannomiya A; Nakajima I; Fuchinoue S; Teraoka S
Int Immunopharmacol; 2006 Dec; 6(13-14):1984-92. PubMed ID: 17161352
[TBL] [Abstract][Full Text] [Related]
4. Results of kidney transplantation in patients receiving MMF- or MMF and basiliximab-containing immunosuppression.
Tojimbara T; Nakajima I; Sato S; Nakamura M; Kawase T; Kai K; Tsuda S; Kudo S; Fuchinoue S; Teraoka S
Transplant Proc; 2004 Sep; 36(7):2087-9. PubMed ID: 15518755
[TBL] [Abstract][Full Text] [Related]
5. Low rate of acute rejection and cytomegalovirus infection in kidney transplant recipients with basiliximab.
Folkmane I; Bicans J; Amerika D; Chapenko S; Murovska M; Rosentals R
Transplant Proc; 2001; 33(7-8):3209-10. PubMed ID: 11750377
[No Abstract] [Full Text] [Related]
6. Efficacy of basiliximab induction therapy in ABO-incompatible kidney transplantation: a rapid steroid withdrawal protocol.
Ando T; Tojimbara T; Sato S; Nakamura M; Kawase T; Kai K; Nakajima I; Fuchinoue S; Teraoka S
Transplant Proc; 2004 Sep; 36(7):2182-3. PubMed ID: 15518793
[TBL] [Abstract][Full Text] [Related]
7. Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation.
Vincenti F; Monaco A; Grinyo J; Kinkhabwala M; Neylan J; Roza A; Somberg K
Transplant Proc; 2001; 33(1-2):1011-2. PubMed ID: 11267168
[No Abstract] [Full Text] [Related]
8. Open-label, multicenter study on the safety, tolerability, and efficacy of Simulect in pediatric renal transplant recipients receiving triple therapy with cyclosporin, mycophenolate, and corticosteroids.
Turconi A; Rilo LR; Goldberg J; de Boccardo G; Garsd A; Otero A
Transplant Proc; 2005 Mar; 37(2):672-4. PubMed ID: 15848497
[TBL] [Abstract][Full Text] [Related]
9. Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol.
Rahamimov R; Yussim A; After T; Lustig S; Bar-Nathan N; Shaharabani E; Shapira Z; Shabthai E; Mor E
Transplant Proc; 2003 Mar; 35(2):653-4. PubMed ID: 12644082
[No Abstract] [Full Text] [Related]
10. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
Montini G; Murer L; Ghio L; Pietrobon B; Ginevri F; Ferraresso M; Cardillo M; Scalamogna M; Perfumo F; Edefonti A; Zanon GF; Zacchello G
Transpl Int; 2005 Jan; 18(1):36-42. PubMed ID: 15612981
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine-sparing effect of basiliximab in renal transplant recipients with mycophenolate mofetil.
Tojimbara T; Sato S; Koyama I; Nanmoku K; Sekijima M; Tonsyo M; Kai K; Kato Y; Urashima Y; Nakajima I; Fuchinoue S; Teraoka S
Transplant Proc; 2005 Mar; 37(2):895-8. PubMed ID: 15848568
[TBL] [Abstract][Full Text] [Related]
12. Results of renal transplantation with different immunosuppressive regimens.
Folkmane I; Bicans J; Chapenko S; Murovska M; Rosentals R
Transplant Proc; 2002 Mar; 34(2):558-9. PubMed ID: 12009623
[No Abstract] [Full Text] [Related]
13. Basiliximab in a triple-drug regimen with tacrolimus and steroids in liver transplantation.
Gruttadauria S; Vasta F; Mandalà L; Cintorino D; Piazza T; Spada M; Verzaro R; Gridelli B
Transplant Proc; 2005; 37(6):2611-3. PubMed ID: 16182762
[TBL] [Abstract][Full Text] [Related]
14. Basiliximab and mycophenolate mofetil in combination with low-dose cyclosporine and methylprednisolone effectively prevent acute rejection in kidney transplant recipients.
Kovac D; Kotnik V; Kandus A
Transplant Proc; 2005 Dec; 37(10):4230-4. PubMed ID: 16387086
[TBL] [Abstract][Full Text] [Related]
15. Current advantage of FK 506 in cadaveric kidney transplantation.
Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
[No Abstract] [Full Text] [Related]
16. Calcineurin inhibitor-free immunosuppression in renal transplantation.
Parada B; Mota A; Nunes P; Macário F; Pratas J; Bastos C; Figueiredo A
Transplant Proc; 2005; 37(6):2759-61. PubMed ID: 16182803
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolate mofetil in living donor renal allograft recipients.
Park K; Moon JI; Kim SI; Kim YS
Transplant Proc; 1999; 31(1-2):1133. PubMed ID: 10083506
[No Abstract] [Full Text] [Related]
18. Effect of basiliximab on renal allograft rejection within 1 year after transplantation.
Lee BM; Oh CK; Jin SH; Kim JH; Kim SJ; Kim H; Shin GT
Transplant Proc; 2006 Sep; 38(7):2025-8. PubMed ID: 16979988
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of calcineurin inhibitors (CNIs) and steroid avoidance immunosuppressive protocol among living donor kidney transplant recipients.
Oh HK; Ding P; Satmary NA
Yonsei Med J; 2004 Dec; 45(6):1143-8. PubMed ID: 15627310
[TBL] [Abstract][Full Text] [Related]
20. Anti-interleukin 2-receptor antibodies: a comparative study with polyclonal antibodies in kidney transplantation: preliminary results.
Martins L; Henriques AC; Dias L; Sarmento AM; Pereira MC; Guimarães S
Transplant Proc; 2000 Dec; 32(8):2623-5. PubMed ID: 11134730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
